C.M. Bidwell & Associates’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ASTH
OAM
C.M. Bidwell & Associates's ASTH Position: Q1 2022 in Review
C.M. Bidwell & Associates sold out of Astrana Health (ASTH) in Q1 2022, closing a stake of 35 shares — an estimated $3K sold.
C.M. Bidwell & Associates first reported a position in ASTH in Q4 2021 and held it in 1 quarter. The position peaked at $3K in Q4 2021. 139 funds tracked by Wall St. Rank hold ASTH as of Q1 2022.
- C.M. Bidwell & Associates reported no remaining Astrana Health position as of Q1 2022 after selling out during the quarter.
- C.M. Bidwell & Associates sold 35 Astrana Health shares in Q1 2022, an estimated $3K.
- C.M. Bidwell & Associates first reported a position in Astrana Health in Q4 2021 and held it in 1 quarter.
- C.M. Bidwell & Associates's Astrana Health position peaked at $3K in Q4 2021.
- 139 funds tracked by Wall St. Rank held Astrana Health as of Q1 2022.
Based on C.M. Bidwell & Associates's 13F filing for Q1 2022, filed 29 Apr 2022.